Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs

Brain Research Reviews

Volumn 58, Issue 1, 2008, Pages 192-208

  Cunha Oliveira, Teresa ^a   Rego, Ana Cristina ^a   Oliveira, Catarina R ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Amphetamine; Apoptosis; Cocaine; Dopamine; Drug of abuse; Glutamate; Heroin; Neurotoxicity; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZOYLECGONINE; CANNABIS; COCAINE; DEXAMPHETAMINE; DIAMORPHINE; DOPAMINE; DRUG METABOLITE; GLUTAMIC ACID; HOMOCOCAINE; HYDROXYAMPHETAMINE; METHAMPHETAMINE; MORPHINE; NORCOCAINE; NOREPHEDRINE; OPIATE; PSYCHOSTIMULANT AGENT;

ACUTE TOXICITY; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN DYSFUNCTION; BRAIN REGION; CHRONIC TOXICITY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG CONTAMINATION; DRUG DEPENDENCE; DRUG METABOLISM; GENE EXPRESSION; HABITUAL ADAPTATION; HUMAN; LONG TERM EXPOSURE; MOLECULAR DYNAMICS; NERVE CELL NECROSIS; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PREVALENCE; PRIORITY JOURNAL; PSYCHOPATHY; REVIEW; REWARD; SUBVENTRICULAR ZONE; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

AMPHETAMINE; ANALGESICS, OPIOID; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; HUMANS; MODELS, BIOLOGICAL; NEUROTOXICITY SYNDROMES; SUBSTANCE-RELATED DISORDERS;

EID: 45549108542     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.03.002     Document Type: Review

References (173)

1. Abekawa T., Ohmori T., and Koyama T. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643 (1994) 276-281
2. Acikgoz O., Gonenc S., Kayatekin B.M., Pekcetin C., Uysal N., Dayi A., Semin I., and Gure A. The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex. Eur. Neuropsychopharmacol. 10 (2000) 415-418
3. Alves E., Summavielle T., Alves C.J., Gomes-Da-Silva J., Barata J.C., Fernandes E., Bastos M.L., Tavares M.A., and Carvalho F. Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J. Neurosci. 27 (2007) 10203-10210
4. Amara S.G., and Kuhar M.J. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16 (1993) 73-93
5. Amato J.L., Bankson M.G., and Yamamoto B.K. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology 32 (2007) 946-954
6. Anderzhanova E., Rayevsky K.S., Saransaari P., Riitamaa E., and Oja S.S. Effects of acute toxic doses of psychostimulants on extracellular levels of excitatory amino acids and taurine in rats: comparison of d-amphetamine and sydnocarb. Ann. N. Y. Acad. Sci. 965 (2002) 193-203
7. Bajo M., Crawford E.F., Roberto M., Madamba S.G., and Siggins G.R. Chronic morphine treatment alters expression of N-methyl-d-aspartate receptor subunits in the extended amygdala. J. Neurosci. Res. 83 (2006) 532-537
8. Bartzokis G., Beckson M., and Ling W. Clinical and MRI evaluation of psychostimulant neurotoxicity. NIDA Res. Monogr. 163 (1996) 300-317
9. Bashkatova V., Meunier J., Vanin A., and Maurice T. Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine. Ann. N. Y. Acad. Sci. 1074 (2006) 632-642
10. Benedi J., Arroyo R., Romero C., Martin-Aragon S., and Villar A.M. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells. Life Sci. 75 (2004) 1263-1276
11. Bhat R.S., Bhaskaran M., Mongia A., Hitosugi N., and Singhal P.C. Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol. 75 (2004) 1131-1138
12. Bisaga A., Comer S.D., Ward A.S., Popik P., Kleber H.D., and Fischman M.W. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology (Berl) 157 (2001) 1-10
13. Bowyer J.F., Frame L.T., Clausing P., Nagamoto-Combs K., Osterhout C.A., Sterling C.R., and Tank A.W. Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. J. Pharmacol. Exp. Ther. 286 (1998) 1074-1085
14. Brown J.M., Hanson G.R., and Fleckenstein A.E. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J. Pharmacol. Exp. Ther. 296 (2001) 762-767
15. Bunney E.B., Appel S.B., and Brodie M.S. Electrophysiological effects of cocaethylene, cocaine, and ethanol on dopaminergic neurons of the ventral tegmental area. J. Pharmacol. Exp. Ther. 297 (2001) 696-703
16. Buttner A., Mall G., Penning R., and Weis S. The neuropathology of heroin abuse. Forensic Sci. Int. 113 (2000) 435-442
17. Cadet J.L., and Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32 (1998) 117-131
18. Cadet J.L., Ordonez S.V., and Ordonez J.V. Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25 (1997) 176-184
19. Cadet J.L., Krasnova I.N., Jayanthi S., and Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res. 11 (2007) 183-202
20. Capela J.P., Meisel A., Abreu A.R., Branco P.S., Ferreira L.M., Lobo A.M., Remiao F., Bastos M.L., and Carvalho F. Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J. Pharmacol. Exp. Ther. 316 (2006) 53-61
21. Capela J.P., Ruscher K., Lautenschlager M., Freyer D., Dirnagl U., Gaio A.R., Bastos M.L., Meisel A., and Carvalho F. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139 (2006) 1069-1081
22. Capela J.P., Fernandes E., Remiao F., Bastos M.L., Meisel A., and Carvalho F. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology 28 (2007) 868-875
23. Capela J.P., Macedo C., Branco P.S., Ferreira L.M., Lobo A.M., Fernandes E., Remião F., Bastos M.L., Dirnagl U., Meisel A., and Carvalho F. Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 146 (2007) 1743-1757
24. Carlezon Jr. W.A., Duman R.S., and Nestler E.J. The many faces of CREB. Trends Neurosci. 28 (2005) 436-445
25. Carvalho F., Fernandes E., Remiao F., Gomes-Da-Silva J., Tavares M.A., and Bastos M.D. Adaptative response of antioxidant enzymes in different areas of rat brain after repeated d-amphetamine administration. Addict Biol. 6 (2001) 213-221
26. Chieng B., and Williams J.T. Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J. Neurosci. 18 (1998) 7033-7039
27. Colado M.I., O'Shea E., Granados R., Murray T.K., and Green A.R. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol. 121 (1997) 889-900
28. Cole R.L., Konradi C., Douglass J., and Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14 (1995) 813-823
29. Cunha-Oliveira T., Rego A.C., Cardoso S.M., Borges F., Swerdlow R.H., Macedo T., and de Oliveira C.R. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res. 1089 (2006) 44-54
30. Cunha-Oliveira T., Rego A.C., Morgadinho M.T., Macedo T., and Oliveira C.R. Chronic effects of heroin and hydrogen peroxide in PC12 cells. Coimbra Médica, V series 2 (2006) 21-29
31. Cunha-Oliveira T., Rego A.C., Morgadinho M.T., Macedo T., and Oliveira C.R. Differential cytotoxic responses of PC12 cells chronically exposed to psychostimulants or to hydrogen peroxide. Toxicology 217 (2006) 54-62
32. Cunha-Oliveira T., Rego A.C., Garrido J., Borges F., Macedo T., and Oliveira C.R. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J. Neurochem. 101 (2007) 543-554
33. Davies K.J. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48 (1999) 41-47
34. Derlet R.W., Albertson T.E., and Rice P. Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol. Biochem. Behav. 36 (1990) 745-749
35. Dey S., Mactutus C.F., Booze R.M., and Snow D.M. Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling. Neuroscience 144 (2007) 509-521
36. Di Chiara G., Tanda G., Bassareo V., Pontieri F., Acquas E., Fenu S., Cadoni C., and Carboni E. Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann. N. Y. Acad. Sci. 877 (1999) 461-485
37. Dietrich J.B., Mangeol A., Revel M.O., Burgun C., Aunis D., and Zwiller J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 48 (2005) 965-974
38. Domingues A., Cunha-Oliveira T., Laco M.L., Macedo T.R., Oliveira C.R., and Rego A.C. Expression of NR1/NR2B N-methyl-d-aspartate receptors enhances heroin toxicity in HEK293 cells. Ann. N. Y. Acad. Sci. 1074 (2006) 458-465
39. Eisch A.J., Barrot M., Schad C.A., Self D.W., and Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7579-7584
40. Eisch A.J., and Harburg G.C. Opiates, psychostimulants, and adult hippocampal neurogenesis: insights for addiction and stem cell biology. Hippocampus 16 (2006) 271-286
41. Ellison G., Eison M.S., Huberman H.S., and Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201 (1978) 276-278
42. Erinoff L. General considerations in assessing neurotoxicity using neuroanatomical methods. Neurochem. Int. 26 (1995) 111-114
43. Ersche K.D., Clark L., London M., Robbins T.W., and Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31 (2006) 1036-1047
44. European Monitoring Centre for Drugs and Drug Addiction. 2007 Annual Report on the State of the Drugs Problem in Europe (2007)
45. Fecho K., and Lysle D.T. Heroin-induced alterations in leukocyte numbers and apoptosis in the rat spleen. Cell. Immunol. 202 (2000) 113-123
46. Fitzmaurice P.S., Tong J., Yazdanpanah M., Liu P.P., Kalasinsky K.S., and Kish S.J. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J. Pharmacol. Exp. Ther. 319 (2006) 703-709
47. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and Hanson G.R. New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 681-698
48. Frenzilli G., Ferrucci M., Giorgi F.S., Blandini F., Nigro M., Ruggieri S., Murri L., Paparelli A., and Fornai F. DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations. Behav. Pharmacol. 18 (2007) 471-481
49. Frey B.N., Valvassori S.S., Gomes K.M., Martins M.R., Dal-Pizzol F., Kapczinski F., and Quevedo J. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 1097 (2006) 224-229
50. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem. Res. 31 (2006) 699-703
51. Gage F.H. Neurogenesis in the adult brain. J. Neurosci. 22 (2002) 612-613
52. Garrido J.M., Marques M.P., Silva A.M., Macedo T.R., Oliveira-Brett A.M., and Borges F. Spectroscopic and electrochemical studies of cocaine-opioid interactions. Anal. Bioanal. Chem. 388 (2007) 1799-1808
53. Gatley S.J., Gifford A.N., Volkow N.D., and Fowler J.S. Pharmacology of cocaine. In: Tarter (Ed). Handbook of Substance Abuse: Neurobehavioral Pharmacology (1998), Plenum Press, New York 161-185
54. Gerfen C.R. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311 (1984) 461-464
55. Gesi M., Ferrucci M., Giusiani M., Lenzi P., Lazzeri G., Alessandri M.G., Salvadorini A., Fulceri F., Pellegrini A., Fornai F., and Paparelli A. Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice. Microsc. Res. Tech. 64 (2004) 297-303
56. Gibb J.W., and Kogan F.J. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch. Pharmacol. 310 (1979) 185-187
57. Goldstein R.Z., and Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 159 (2002) 1642-1652
58. Graham D.G., Tiffany S.M., Bell Jr. W.R., and Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14 (1978) 644-653
59. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
60. Guzman D.C., Vazquez I.E., Brizuela N.O., Alvarez R.G., Mejia G.B., Garcia E.H., Santamaria D., de Apreza M.R., and Olguin H.J. Assessment of oxidative damage induced by acute doses of morphine sulfate in postnatal and adult rat brain. Neurochem. Res. 31 (2006) 549-554
61. Hastings T.G., Lewis D.A., and Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1956-1961
62. Hu S., Sheng W.S., Lokensgard J.R., and Peterson P.K. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42 (2002) 829-836
63. Huber J.D., Darling S.F., Park K.K., and Soliman K.F. The role of NMDA receptors in neonatal cocaine-induced neurotoxicity. Pharmacol. Biochem. Behav. 69 (2001) 451-459
64. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 565-598
65. Iacovelli L., Fulceri F., De B.A., Nicoletti F., Ruggieri S., and Fornai F. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders. Exp. Neurol. 201 (2006) 24-31
66. Imam S.Z., Duhart H.M., Skinner J.T., and Ali S.F. Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells: a possible mechanism of neurotoxic damage in cocaine addiction. Ann. N. Y. Acad. Sci. 1053 (2005) 482-490
67. Imam S.Z., Itzhak Y., Cadet J.L., Islam F., Slikker Jr. W., and Ali S.F. Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice. Brain Res. Mol. Brain Res. 91 (2001) 174-178
68. Jackson G.R., Sampath D., Werrbach-Perez K., and Perez-Polo J.R. Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone. Brain Res. 634 (1994) 69-76
69. Jang J.H., and Surh Y.J. Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death. Redox. Rep. 9 (2004) 343-348
70. Jatlow P., McCance E.F., Bradberry C.W., Elsworth J.D., Taylor J.R., and Roth R.H. Alcohol plus cocaine: the whole is more than the sum of its parts. Ther. Drug. Monit. 18 (1996) 460-464
71. Jayanthi S., Ladenheim B., Andrews A.M., and Cadet J.L. Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy). Neuroscience 91 (1999) 1379-1387
72. Jenkins A.J., and Cone E.J. Pharmacokinetics: drug absorption, distribution, and elimination. In: Karch S.B. (Ed). Drug Abuse Handbook (1998), CRC Press LLC 165-215
73. Jimenez A., Jorda E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., Escubedo E., Camarasa J., Camins A., and Pallas M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 196 (2004) 223-234
74. Johnson E.A., O'Callaghan J.P., and Miller D.B. Brain concentrations of d-MDMA are increased after stress. Psychopharmacology (Berl) 173 (2004) 278-286
75. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., and Wightman R.M. Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73 (1999) 2406-2414
76. Jones D.C., Gunasekar P.G., Borowitz J.L., and Isom G.E. Dopamine-induced apoptosis is mediated by oxidative stress and Is enhanced by cyanide in differentiated PC12 cells. J. Neurochem. 74 (2000) 2296-2304
77. Kahlig K.M., Binda F., Khoshbouei H., Blakely R.D., McMahon D.G., Javitch J.A., and Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3495-3500
78. Kalivas P.W., and Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem. 70 (1998) 1497-1502
79. Kato H., Narita M., Suzuki M., Yoshimoto K., Yasuhara M., and Suzuki T. Role of tyrosine kinase-dependent phosphorylation of NR2B subunit-containing NMDA receptor in morphine reward. Nihon Arukoru Yakubutsu Igakkai Zasshi 42 (2007) 13-20
80. Koppel B.S., Samkoff L., and Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia 37 (1996) 875-878
81. Krasnova I.N., Ladenheim B., and Cadet J.L. Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. FASEB J. 19 (2005) 851-853
82. Kreek M.J., Laforge K.S., and Butelman E. Pharmacotherapy of addictions. Nat. Rev. Drug Discov. 1 (2002) 710-726
83. Kroemer G., and Martin S.J. Caspase-independent cell death. Nat. Med. 11 (2005) 725-730
84. Kuczenski R. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase. Neuropharmacology 14 (1975) 1-10
85. Langendorf F.G., Anderson D.C., Tupper D.E., Rottenberg D.A., and Weisman I.D. Brain atrophy and chronic cocaine abuse: background and work in progress. NIDA Res. Monogr. 163 (1996) 27-42
86. Leshner A.I. Addiction is a brain disease, and it matters. Science 278 (1997) 45-47
87. Li M.O., Sarkisian M.R., Mehal W.Z., Rakic P., and Flavell R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302 (2003) 1560-1563
88. Lim G., Wang S., Lim J.A., and Mao J. Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis. Neurosci Lett. 389 (2005) 104-108
89. Lipton J.W., Gyawali S., Borys E.D., Koprich J.B., Ptaszny M., and McGuire S.O. Prenatal cocaine administration increases glutathione and alpha-tocopherol oxidation in fetal rat brain. Brain Res. Dev. Brain Res. 147 (2003) 77-84
90. Liu X.Y., Chu X.P., Mao L.M., Wang M., Lan H.X., Li M.H., Zhang G.C., Parelkar N.K., Fibuch E.E., Haines M., Neve K.A., Liu F., Xiong Z.G., and Wang J.Q. Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52 (2006) 897-909
91. Logan B.J., Laverty R., Sanderson W.D., and Yee Y.B. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur. J. Pharmacol. 152 (1988) 227-234
92. Lyoo I.K., Streeter C.C., Ahn K.H., Lee H.K., Pollack M.H., Silveri M.M., Nassar L., Levin J.M., Sarid-Segal O., Ciraulo D.A., Renshaw P.F., and Kaufman M.J. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 131 (2004) 135-145
93. Ma Y.Y., Guo C.Y., Yu P., Lee D.Y., Han J.S., and Cui C.L. The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats. Exp. Neurol. 200 (2006) 343-355
94. Ma Y.Y., Chu N.N., Guo C.Y., Han J.S., and Cui C.L. NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp. Neurol. 203 (2007) 309-319
95. Macedo D.S., de Vasconcelos S.M., dos Santos R.S., Aguiar L.M., Lima V.T., Viana G.S., and de Sousa F.C. Cocaine alters catalase activity in prefrontal cortex and striatum of mice. Neurosci. Lett. 387 (2005) 53-56
96. Mackowiak M., Markowicz-Kula K., Fijal K., and Wedzony K. Acute and repeated administration of cocaine differentially regulates expression of PSA-NCAM-positive neurons in the rat hippocampus. Brain Res. 1055 (2005) 149-155
97. Majewska M.D. Cocaine addiction as a neurological disorder: implications for treatment. NIDA Res. Monogr. 163 (1996) 1-26
98. Mao J., Sung B., Ji R.R., and Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J. Neurosci. 22 (2002) 7650-7661
99. Martin G., Guadano-Ferraz A., Morte B., Ahmed S., Koob G.F., De L.L., and Siggins G.R. Chronic morphine treatment alters N-methyl-d-aspartate receptors in freshly isolated neurons from nucleus accumbens. J. Pharmacol. Exp. Ther. 311 (2004) 265-273
100. McLaughlin B.A., Nelson D., Erecinska M., and Chesselet M.F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. 70 (1998) 2406-2415
101. Milhazes N., Cunha-Oliveira T., Martins P., Garrido J., Oliveira C., Rego A.C., and Borges F. Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: a putative structure-toxicity relationship. Chem. Res. Toxicol. 19 (2006) 1294-1304
102. Mirecki A., Fitzmaurice P., Ang L., Kalasinsky K.S., Peretti F.J., Aiken S.S., Wickham D.J., Sherwin A., Nobrega J.N., Forman H.J., and Kish S.J. Brain antioxidant systems in human methamphetamine users. J. Neurochem. 89 (2004) 1396-1408
103. Mitchell E.S., and Snyder-Keller A. c-fos and cleaved caspase-3 expression after perinatal exposure to ethanol, cocaine, or the combination of both drugs. Brain Res. Dev. Brain Res. 147 (2003) 107-117
104. Murray F., Harrison N.J., Grimwood S., Bristow L.J., and Hutson P.H. Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats. Eur. J. Pharmacol. 562 (2007) 191-197
105. Naqvi N.H., Rudrauf D., Damasio H., and Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science 315 (2007) 531-534
106. Nash J.F., Roth B.L., Brodkin J.D., Nichols D.E., and Gudelsky G.A. Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neurosci. Lett. 177 (1994) 111-115
107. Nassogne M.C., Louahed J., Evrard P., and Courtoy P.J. Cocaine induces apoptosis in cortical neurons of fetal mice. J. Neurochem. 68 (1997) 2442-2450
108. Nassogne M.C., Evrard P., and Courtoy P.J. Selective direct toxicity of cocaine on fetal mouse neurons. Teratogenic implications of neurite and apoptotic neuronal loss. Ann. N. Y. Acad. Sci. 846 (1998) 51-68
109. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
110. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl 1 (2004) 24-32
111. Nixon K., and Crews F.T. Temporally specific burst in cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol. J. Neurosci. 24 (2004) 9714-9722
112. Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States 1992-2002 (2004), 20503: Office of the National Drug Control Policy, Washington, D.C.
113. Oliveira M.T., Rego A.C., Macedo T.R., and Oliveira C.R. Drugs of abuse induce apoptotic features in PC12 cells. Ann. N. Y. Acad. Sci. 1010 (2003) 667-670
114. Oliveira M.T., Rego A.C., Morgadinho M.T., Macedo T.R., and Oliveira C.R. Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Ann. N. Y. Acad. Sci. 965 (2002) 487-496
115. Olsen G.D. Potential mechanisms of cocaine-induced developmental neurotoxicity: a minireview. Neurotoxicology 16 (1995) 159-167
116. Ozmen I., Naziroglu M., Alici H.A., Sahin F., Cengiz M., and Eren I. Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress. Neurochem. Res. 32 (2007) 19-25
117. Pau C.W.H., Lee T.M.C., and Chan S.F.F. The impact of heroin on frontal executive functions. Arch. Clin. Neuropsychol. 17 (2002) 663-670
118. Pearson J., Baden M.B., and Richter R.W. Neuronal depletion in the globus pallidus of heroin addicts. Drug Alcohol Depend. 1 (1976) 349-356
119. Pereira F.C., Santos S.D., Ribeiro C.F., Ali S.F., and Macedo T.R. A single exposure to morphine induces long-lasting hyporeactivity of rat caudate putamen dopaminergic nerve terminals. Ann. N. Y. Acad. Sci. 1025 (2004) 414-423
120. Pereira F.C., Lourenco E., Milhazes N., Morgadinho T., Ribeiro C.F., Ali S.F., and Macedo T.R. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats. Ann. N. Y. Acad. Sci. 1074 (2006) 160-173
121. Pereira F.C., Lourenco E.S., Borges F., Morgadinho T., Ribeiro C.F., Macedo T.R., and Ali S.F. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Synapse 60 (2006) 185-193
122. Poon H.F., Abdullah L., Mullan M.A., Mullan M.J., and Crawford F.C. Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem. Int. 50 (2007) 69-73
123. Pubill D., Chipana C., Camins A., Pallas M., Camarasa J., and Escubedo E. Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol. Appl. Pharmacol. 204 (2005) 57-68
124. Qiusheng Z., Yuntao Z., Rongliang Z., Dean G., and Changling L. Effects of verbascoside and luteolin on oxidative damage in brain of heroin treated mice. Pharmazie 60 (2005) 539-543
125. Ramsay R.R., and Hunter D.J. Inhibitors alter the spectrum and redox properties of monoamine oxidase A. Biochim. Biophys. Acta 1601 (2002) 178-184
126. Rego A.C., and Oliveira C.R. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28 (2003) 1563-1574
127. Reid M.S., Hsu Jr. K., and Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27 (1997) 95-105
128. Rhodes J.S., and Crabbe J.C. Gene expression induced by drugs of abuse. Curr. Opin. Pharmacol. 5 (2005) 26-33
129. Ribeiro Do Couto B., Aguilar M.A., Manzanedo C., Rodriguez-Arias M., and Minarro J. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 1035-1043
130. Riddle E.L., Topham M.K., Haycock J.W., Hanson G.R., and Fleckenstein A.E. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur. J. Pharmacol. 449 (2002) 71-74
131. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
132. Rogers R.D., and Robbins T.W. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr. Opin. Neurobiol. 11 (2001) 250-257
133. Rose J.S., Branchey M., Buydens-Branch, Stapleton J.M., Chasten K., Werrell A., and Maayan M.L. Cerebral perfusion in early and late opiate withdrawal: a technetium-99m-HMPAO SPECT study. Psychiatry Res. 67 (1996) 39-47
134. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
135. Sawynok J. The therapeutic use of heroin: a review of the pharmacological literature. Can. J. Physiol. Pharmacol. 64 (1986) 1-6
136. Scheggi S., Mangiavacchi S., Masi F., Gambarana C., Tagliamonte A., and De Montis M.G. Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects. Neuroscience 109 (2002) 267-274
137. Schilstrom B., Yaka R., Argilli E., Suvarna N., Schumann J., Chen B.T., Carman M., Singh V., Mailliard W.S., Ron D., and Bonci A. Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J. Neurosci. 26 (2006) 8549-8558
138. Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., and Gibb J.W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233 (1985) 539-544
139. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse 40 (2001) 55-64
140. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 385 (1999) 103-110
141. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., and Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl) 165 (2003) 359-369
142. Siggins G.R., Martin G., Roberto M., Nie Z., Madamba S., and De L.L. Glutamatergic transmission in opiate and alcohol dependence. Ann. N. Y. Acad. Sci. 1003 (2003) 196-211
143. Sitte H.H., Huck S., Reither H., Boehm S., Singer E.A., and Pifl C. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71 (1998) 1289-1297
144. Sonsalla P.K. The role of N-methyl-d-aspartate receptors in dopaminergic neuropathology produced by the amphetamines. Drug Alcohol Depend. 37 (1995) 101-105
145. Sonsalla P.K., Nicklas W.J., and Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243 (1989) 398-400
146. Sprague J.E., and Nichols D.E. The monoamine oxidase-B inhibitor l-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J. Pharmacol. Exp. Ther. 273 (1995) 667-673
147. Stumm G., Schlegel J., Schafer T., Wurz C., Mennel H.D., Krieg J.C., and Vedder H. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13 (1999) 1065-1072
148. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., and Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15 (1995) 4102-4108
149. Sulzer D., Sonders M.S., Poulsen N.W., and Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75 (2005) 406-433
150. Teuchert-Noodt G., Dawirs R.R., and Hildebrandt K. Adult treatment with methamphetamine transiently decreases dentate granule cell proliferation in the gerbil hippocampus. J. Neural Transm. 107 (2000) 133-143
151. Tramullas M., Martinez-Cue C., and Hurle M.A. Chronic administration of heroin to mice produces up-regulation of brain apoptosis-related proteins and impairs spatial learning and memory. Neuropharmacology 54 (2008) 640-652
152. Trujillo K.A. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 121-141
153. Tzschentke T.M., and Schmidt W.J. N-methyl-d-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193 (1995) 37-40
154. Tzschentke T.M., and Schmidt W.J. Glutamatergic mechanisms in addiction. Mol. Psychiatry 8 (2003) 373-382
155. Uhl G.R., and Grow R.W. The burden of complex genetics in brain disorders. Arch. Gen. Psychiatry 61 (2004) 223-229
156. United Nations Office on Drugs and Crime. World Drug Report 2007. United Nations Office on Drugs and Crime (2007)
157. Volkow N.D., and Li T.K. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol. Ther. 108 (2005) 3-17
158. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: insights from imaging studies. J. Clin. Invest. 111 (2003) 1444-1451
159. Volkow N.D., Fowler J.S., Wang G.J., and Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9 (2004) 557-569
160. Warren M.W., Larner S.F., Kobeissy F.H., Brezing C.A., Jeung J.A., Hayes R.L., Gold M.S., and Wang K.K. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA. Acta Neuropathol. 114 (2007) 277-286
161. Wiese A.G., Pacifici R.E., and Davies K.J. Transient adaptation of oxidative stress in mammalian cells. Arch. Biochem. Biophys. 318 (1995) 231-240
162. Williams J.M., and Steketee J.D. Cocaine increases medial prefrontal cortical glutamate overflow in cocaine-sensitized rats: a time course study. Eur. J. Neurosci. 20 (2004) 1639-1646
163. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54 (1998) 679-720
164. Wolf M.E., and Xue C.J. Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex. J. Neurochem. 73 (1999) 1529-1538
165. Wolf S.L., and Mikhael M.A. Computerized transaxial tomographic and neuropsychol evaluations in chronic alcoholics and heroin abusers. Am. J. Psychiatry 136 (1979) 598-602
166. Wu C.W., Ping Y.H., Yen J.C., Chang C.Y., Wang S.F., Yeh C.L., Chi C.W., and Lee H.C. Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol. Appl. Pharmacol. 220 (2007) 243-251
167. Xi Z.X., and Stein E.A. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat. Psychopharmacology (Berl) 164 (2002) 144-150
168. Xu B., Wang Z., Li G., Li B., Lin H., Zheng R., and Zheng Q. Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome. Basic Clin. Pharmacol. Toxicol. 99 (2006) 153-161
169. Yamaguchi M., Suzuki T., Abe S., Hori T., Kurita H., Asada T., Okado N., and Arai H. Repeated cocaine administration differentially affects NMDA receptor subunit (NR1, NR2A-C) mRNAs in rat brain. Synapse 46 (2002) 157-169
170. Yamaguchi M., Suzuki T., Seki T., Namba T., Juan R., Arai H., Hori T., and Asada T. Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus. Ann. N. Y. Acad. Sci. 1025 (2004) 351-362
171. Yamamoto B.K., and Bankson M.G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 17 (2005) 87-117
172. You Z.B., Wang B., Zitzman D., Azari S., and Wise R.A. A role for conditioned ventral tegmental glutamate release in cocaine seeking. J. Neurosci. 27 (2007) 10546-10555
173. Zhu J.P., Xu W., and Angulo J.A. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 140 (2006) 607-622